Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05873387 · ClinicalTrials.gov registry record
Development of an Algorithm to Detect Pulmonary Hypertension Using an Electronic Stethoscope
A clinical trial of Pulmonary Hypertension, sponsored by Eko Devices.
- Recruiting
- Registry status
- 2,420
- Enrollment target
- 3
- Study locations
NCT05873387: Recruiting study of Pulmonary Hypertension, sponsored by Eko Devices.
NCT05873387 is a study of Pulmonary Hypertension that is actively recruiting participants, run by Eko Devices. The registered enrollment target is 2,420 participants, above the 580-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (317% higher). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05873387, a study of Pulmonary Hypertension, is actively recruiting participants, sponsored by Eko Devices.
- RECRUITING
- Registry status
- 2,420 participants
- Enrollment target
- 3
- Study locations
Study Summary
The major goal of the study is to determine whether phonocardiography (using the Eko DUO stethoscope which can capture a three lead ECG reading) can present features that relate to the presence of PH diagnosed by echocardiography or right heart catheterization (RHC), and therefore have a potential to assist the provider to suspect PH.
Primary Outcome
Create a training/validation dataset composed of ECG/PCG recordings by enrolling at least 2200 subjects undergoing echocardiography and at least 220 subjects who have undergone right heart catheterization (RHC)
Conditions Studied
Interventions
- DEVICE Use of Eko DUO stethoscope (paired ECG/PCG)
Study Locations (3)
Rhode Island
- Rhode Island Hospital - Providence
- The Miriam Hospital - Providence
- Providence VA Medical Center - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,420 participants |
| Start Date | 2023-07-12 |
| Est. Completion | 2026-12 |
What NCT05873387 shows while recruiting
NCT05873387 is an observational study that tracks outcomes without assigning an intervention. Its 2,420 participants enrollment target places it among the larger protocols in the corpus, above the 580-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (317% higher).
The record links to 1 condition, with Pulmonary Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Use of Eko DUO stethoscope (paired ECG/PCG) is the first listed.
NCT05873387 reports a single indexed study location in Rhode Island.
Frequently Asked Questions
What is clinical trial NCT05873387 about?
NCT05873387 is a clinical study titled "Development of an Algorithm to Detect Pulmonary Hypertension Using an Electronic Stethoscope". The major goal of the study is to determine whether phonocardiography (using the Eko DUO stethoscope which can capture a three lead ECG reading) can present features that relate to the presence of PH diagnosed by echocardiography or right heart catheterization (RHC), and therefore have a potential t...
What is the current status of trial NCT05873387?
This trial is currently recruiting. The enrollment target is 2,420 participants. The study started on 2023-07-12. Estimated completion is 2026-12.
What conditions does trial NCT05873387 study?
This clinical trial studies the following conditions: Pulmonary Hypertension.
What interventions are being tested in trial NCT05873387?
The interventions under investigation include: Use of Eko DUO stethoscope (paired ECG/PCG) (DEVICE).
Who is sponsoring clinical trial NCT05873387?
This trial is sponsored by Eko Devices, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05873387 being conducted?
This trial has 3 study locations across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05873387's enrollment target sits among peer trials
2,420 7th of 72 higher than 66 of 72 other Pulmonary Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pulmonary Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection
RECRUITING
-
Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
RECRUITING · NA
-
Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders
RECRUITING
-
LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF
RECRUITING · Phase 3
-
Hemodynamic Assessment of underLying myocyTe Function in Right Heart Failure
RECRUITING
-
A Trial of Phosphodiesterase-5 Inhibitor in Neonatal Congenital Diaphragmatic Hernia (TOP-CDH)
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05345951 · 2,425 participants · NA
Project e-PBI+ - Parent Intervention to Reduce College Student Drinking and Cannabis Use
- NCT06676904 · 2,433 participants · NA
Neonatal Platelet Transfusion Threshold Trial
- NCT06128304 · 2,436 participants · NA
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
- NCT05185440 · 2,400 participants · NA
Reducing Alcohol Involved Sexual Violence in Higher Education
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI